全文获取类型
收费全文 | 39930篇 |
免费 | 3056篇 |
国内免费 | 1165篇 |
专业分类
耳鼻咽喉 | 331篇 |
儿科学 | 732篇 |
妇产科学 | 1019篇 |
基础医学 | 4735篇 |
口腔科学 | 1182篇 |
临床医学 | 5005篇 |
内科学 | 4659篇 |
皮肤病学 | 672篇 |
神经病学 | 2489篇 |
特种医学 | 1792篇 |
外国民族医学 | 10篇 |
外科学 | 6191篇 |
综合类 | 5526篇 |
现状与发展 | 7篇 |
一般理论 | 6篇 |
预防医学 | 3043篇 |
眼科学 | 756篇 |
药学 | 2158篇 |
25篇 | |
中国医学 | 957篇 |
肿瘤学 | 2856篇 |
出版年
2024年 | 60篇 |
2023年 | 1693篇 |
2022年 | 2406篇 |
2021年 | 2779篇 |
2020年 | 2835篇 |
2019年 | 1780篇 |
2018年 | 1429篇 |
2017年 | 1605篇 |
2016年 | 1636篇 |
2015年 | 1934篇 |
2014年 | 3285篇 |
2013年 | 2960篇 |
2012年 | 3173篇 |
2011年 | 2999篇 |
2010年 | 2594篇 |
2009年 | 2197篇 |
2008年 | 1311篇 |
2007年 | 1595篇 |
2006年 | 1257篇 |
2005年 | 701篇 |
2004年 | 408篇 |
2003年 | 213篇 |
2002年 | 254篇 |
2001年 | 228篇 |
2000年 | 203篇 |
1999年 | 237篇 |
1998年 | 209篇 |
1997年 | 178篇 |
1996年 | 206篇 |
1995年 | 173篇 |
1994年 | 119篇 |
1993年 | 96篇 |
1992年 | 123篇 |
1991年 | 151篇 |
1990年 | 158篇 |
1989年 | 119篇 |
1988年 | 160篇 |
1987年 | 69篇 |
1986年 | 31篇 |
1985年 | 56篇 |
1984年 | 62篇 |
1983年 | 43篇 |
1982年 | 47篇 |
1981年 | 65篇 |
1980年 | 40篇 |
1979年 | 43篇 |
1978年 | 27篇 |
1977年 | 33篇 |
1975年 | 28篇 |
1974年 | 40篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
《Survey of ophthalmology》2022,67(3):659-674
The human eye has a unique immune architecture and behavior. While the conjunctiva is known to have a well-defined lymphatic drainage system, the cornea, sclera, and uveal tissues were historically considered “alymphatic” and thought to be immune privileged. The very fact that the aqueous outflow channels carry a clear fluid (aqueous humor) along the outflow pathway makes it hard to ignore its lymphatic-like characteristics. The development of novel lymphatic lineage markers and expression of these markers in aqueous outflow channels and improved imaging capabilities has sparked a renewed interest in the study of ocular lymphatics. Ophthalmic lymphatic research has had a directional shift over the last decade, offering an exciting new physiological platform that needs further in-depth understanding. The evidence of a presence of distinct lymphatic channels in the human ciliary body is gaining significant traction. The uveolymphatic pathway is an alternative new route for aqueous outflow and adds a new dimension to pathophysiology and management of glaucoma. Developing novel animal models, markers, and non-invasive imaging tools to delineate the core anatomical structure and physiological functions may help pave some crucial pathways to understand disease pathophysiology and help develop novel targeted therapeutic approaches for glaucoma. 相似文献
13.
14.
15.
BackgroundThe success of surgical repairs rely on the effectiveness and integrity of the surgical knots used to secure the repair. The purpose of this study is to examine and compare the performance of the Nice knot, the modified Nice knot, and a commonly used combination of surgeons' and square knots with respect to cyclic loading and load-to-failure usiflueng a high-strength suture composed of ultra-high molecular weight polyethylene in the hands of experienced surgeons.MethodsTwo experienced surgeons threw 3 different knot types 9 times, consisting of the Nice knot, modified Nice knot, and a surgeon's knot utilizing Ultrabraid #2 sutures. Each knot was subject to cyclic loading and load to failure testing.FindingsBoth surgeons had similar displacement data for the surgeon's knot, while the identity of the surgeon impacted displacement for the Nice knot (p = 0.03) and the modified Nice knot (p = 0.0002). The load to failure for the modified Nice knot (p < 0.001) and the Nice knot (p = 0.001) were significantly impacted by the surgeon tying the knot, while the surgeon's knot was not. Specimens failed where the sutures passed through the loop at the “base” of the knot.InterpretationsThe strength and integrity of complex surgical knots are variable between surgeons. While the proposed Modified Nice Knot has a theoretical advantage because the half hitches reinforce the primary knot, in load to failure testing both the Modified Nice Knot and the Nice Knot failed where the suture passed through the loop in the primary knot. 相似文献
16.
《Journal of Medical Imaging and Radiation Sciences》2022,53(3):460-470
PurposeTo provide means for calculating the dose received by various tissues of the patient, calculate lung shield, and verify received dose using a phantom as a tool for quality assurance for a planned Total Body Irradiation (TBI) procedure in radiotherapy.MethodUsing Microsoft Visual Basic, MATLAB, and Python, a program for Total Body Irradiation Calculation in Radiotherapy (TBICR) is constructed. It uses patient translation and beam zone method for total body irradiation calculations to compute the proper dose received by the patient and determine the lung shield thickness. There are three main user-friendly interfaces in the application. The first one allows the user to upload the TBI topography and estimate the distances needed for TBI calculations. The second one enables the user to count the number of beam zones needed for each point and estimate the effective area (Aeff) for each level. The third interface estimates the velocity required to deliver the relative dose depending on patient separation, Monitor Units (MU), couch speed and travel distance. It allows the user to compute the required lung shield thickness, read any patient's CT DICOM file and acquire dose in any distinct location using machine learning model to predict the dose.ResultsThe TBICR software has been successfully validated by reproducing all of the manual calculations in an exact and timely manner. TBICR generated more accurate results and confirmed the absorbed dose to patient through measurements on Anderson phantom.ConclusionsA computer program for the calculation of total body irradiation (TBI) is described in full. The dose received at each point on the patient, the calculation of lung shield and the determination of the velocity and time required for the couch movement are all made possible using the software. The ease of use, precision, data storage and printing are some important features of the present software. 相似文献
17.
18.
《Digestive and liver disease》2022,54(11):1486-1493
BackgroundCold snare polypectomy (CSP) is a promising technique for the removal of sessile serrated polyps (SSPs) ≥ 10 mm. However, the efficacy and safety of this technique remain undetermined.AimsWe aimed to comprehensively evaluate the efficacy and safety of CSP for SSPs ≥ 10 mm.MethodsPubMed, EMBASE, Web of Science and Cochrane Library were searched up to January 2021.ResultsA total of 10 studies consisting of 1727 SSPs (range, 10–40 mm) from 1021 patients were included. The overall rates of technical success, adverse events (AEs) and residual SSPs were 100%, 0.7% and 2.9%, respectively. Subgroup analysis showed that the rates of technical success and AEs were comparable between CSP and cold endoscopic mucosal resection (EMR) (99.9% vs. 100% and 1.3% vs. 0.5%, respectively), between the proximal and distal colon (100% vs. 99.9% and 0.3% vs. 0, respectively), and between polyps of 10–19 mm and ≥20 mm (99.8% vs. 100% and 0.9% vs. 0, respectively). However, subgroup analysis showed that the rate of residual SSPs was slightly lower in CSP compared with cold EMR (1.3% vs. 3.9%), as well as in polyps of 10–19 mm compared with those ≥20 mm (3.1% vs. 4.7%).ConclusionCSP was an effective and safe technique for removing SSPs ≥ 10 mm. 相似文献
19.
《Clinical therapeutics》2022,44(7):1012-1025
Statins, or 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are the mainstay of treatment for hypercholesterolemia as they effectively reduce LDL-C levels and risk of atherosclerotic cardiovascular disease. Apart from hyperglycemia, dyslipidemia and HDL dysfunction are known risk factors for neuropathy in people with obesity and diabetes. Although there are case reports of statin-induced neuropathy, ad hoc analyses of clinical trials and observational studies have shown that statins may improve peripheral neuropathy. However, large randomized controlled trials and meta-analyses of cardiovascular outcome trials with statins and other lipid-lowering drugs have not reported on neuropathy outcomes. Because neuropathy was not a prespecified outcome in major cardiovascular trials, one cannot conclude whether statins or other lipid-lowering therapies increase or decrease the risk of neuropathy. The aim of this review was to assess if statins have beneficial or detrimental effects on neuropathy and whether there is a need for large well-powered interventional studies using objective neuropathy end points. 相似文献
20.